• Home
  • About
  • News
  • Contact
  • Rinn Network ↗

FUNDED BY

EPSRC-SFI Centre for Doctoral Training (CDT) in Transformative Pharmaceutical Technologies

EPSRC-SFI Centre for Doctoral Training (CDT) in Transformative Pharmaceutical Technologies

by tr0han | Sep 12, 2023 | Biologics, Health, Impact, Small Molecule, Sustainability

EPSRC-SFI Centre for Doctoral Training (CDT) in Transformative Pharmaceutical Technologies. The CDT is funded through a partnership between the Engineering and Physical Sciences Research Council (EPSRC) in the UK, and Science Foundation Ireland. Website:...

Multi-Product Resin Reuse for Biopharmaceutical Manufacturing

by tr0han | Aug 14, 2023 | Biologics, Health, Impact, Sustainability

SSPC are working with Pfizer, Eli Lilly, Johnson & Johnson, BMS and MSD to address the global protein A resin shortage, under the direction of SSPC Principal Investigator Professor Sarah Hudson, University of Limerick. Many of the challenges include the rising...

RACE: Raw Communications and Engagement

by tr0han | Aug 14, 2023 | Education & Public Engagement, Impact, Sustainability

Researchers: Dr Sarah Hayes, Martin McHugh and Dr Aimee Stapleton, SSPC, University of Limerick. Prof. Felix Ho and Prof. Daniel Brandell, Uppsala University. Dr Paul McCrory, Prof. Jarkko Ketolainen and Prof. Ossi Korhonen, University of Eastern Finland and Prof....

Cyanide-free cyanation reactions in continuous flow mode

by tr0han | Aug 14, 2023 | Impact, Small Molecule, Sustainability

The pharmaceutical and fine chemical industry continues to innovate and as new chemical identities (NCEs) are selected, contract and development manufacturing organisations (CDMOs) like Almac need to have an armoury of technologies at their disposal to be able to...

Modelling of Multi-Phase Transport Processes to enable automation in manufacturing

by tr0han | May 25, 2023 | Biologics, Impact, Small Molecule, Sustainability

The Challenge The MOMEnTUM Spoke project is centred along diagnostic themes in specific areas of process modelling to enable control and automation within “substance” processing. The manufacture of pharmaceutics, biopharmaceutics, and chemical products is complex and...

De Souza Process – Pregabalin: Transformed Crystallization

by tr0han | May 25, 2023 | Impact, Small Molecule, Sustainability

The Challenge and background The recrystallization of Pregabalin in Isopropyl Alcohol (IPA) and Water is complex and does not follow a normal linear relationship. Pfizer circumvented this problem by elaborate azeotropic distillations to change solvent ratios post...
« Older Entries
Next Entries »

Recent Posts

  • Rinn Pharma & Biopharma PhD opportunities – Positions available 07.10.2026
  • Sarah Hayes Named Biopharma & Lifesciences Connected Person of the Month for June 2026
  • Rinn Pharma & Biopharma Expands European Research Collaboration Through NordicPharmaTrain Partnership
  • Rinn Pharma & Biopharma and ArrayPatch Collaborate to Advance Novel Intradermal Therapy
  • Jordan Loughlin SSPC industry placement at Clarochem

Recent Comments

No comments to show.

Research & Innovation in Making Medicines. Part of the Rinn Network — Radical Collaboration.

CONTACT

Rinn Pharma & Biopharma
Bernal Institute,
University of Limerick,
Ireland

Tel: +353 61 233754

FOLLOW

  • Follow
  • Follow
  • Follow

FUNDED BY

© 2026 Rinn Pharma & Biopharma

Privacy PolicyCookie Policy

Disclaimer

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}